Brian Stemme is project director for BioCrossroads. He has a strong background in life sciences market development and research. He is responsible for identifying and developing opportunities for growth within Indiana’s life sciences sector, evaluating early-stage companies for investment by BioCrossroads’ seed funds and supporting the State’s efforts to attract and grow life sciences companies.
Brian led the formation of the Central Indiana Corporate Partnership’s AgriNovus Indiana, a nonprofit established in 2013 to leverage Indiana’s strengths in agricultural innovation, working with industry CEOs, Indiana’s Lieutenant Governor and Purdue University to launch the new entity, publish a first-of-its-kind report and support early-stage ag-tech companies.
He is a member of the board of directors of Allinaire Therapeutics.
Prior to joining BioCrossroads, Brian was employed by Eli Lilly and Company in Corporate Affairs, where he ran the company’s political action committee. He also worked as a Senior Analyst in the company’s biotechnology unit and was a member of the team that established Lilly Systems Biology, Ltd. in Singapore. Previously, Brian was a manager in Arthur Andersen’s Assurance practice, providing audit and tax consulting to companies in the energy, software and healthcare industries.Back to Team